Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 15:170:247-253.
doi: 10.1016/j.carbpol.2017.04.071. Epub 2017 Apr 27.

Double-coated enrofloxacin microparticles with chitosan and alginate: Preparation, characterization and taste-masking effect study

Affiliations

Double-coated enrofloxacin microparticles with chitosan and alginate: Preparation, characterization and taste-masking effect study

Mengxi Liu et al. Carbohydr Polym. .

Abstract

Enrofloxacin (ENRO) is widely used as an antimicrobial drug for treatment of uncomplicated and complicated infections in veterinary medicine. Its bitter taste limits its clinical applications in veterinary. To mask the bitter taste of this drug, double-coated taste-masking microparticles of ENRO (DTME) were prepared through stearic acid solid dispersion and chitosan-alginate microparticle coating technologies. The taste-masking effect was evaluated by pig feeding experiment. Results showed that DTME exhibited a spherical-like shape (170490μm). DTME yielded a drug loading rate of DTME 20.3% and an entrapment efficiency of 89.8%. The bitter detection threshold value of ENRO for pigs is 2μg/mL. The drug release amounts of DTME within 30s were less than 2μg/mL in artificial saliva. Compared with normal food intake, the food intake of pigs decreased 28.65% when fed with fodder containing free ENRO and slightly increased (0.18%) when fed with fodder containing DTME. Therefore, DTME masked the bitterness of ENRO and improved its palatability. In conclusion, DTME showed satisfactory bitter taste-masking property; this novel formulation was likely to provide more selectable dosage forms for ENRO.

Keywords: Anhydrous calcium chloride (PubChem CID: 24854); Bitter taste detection threshold; Chitosan (PubChem CID: 71853); Citrosodine (PubChem CID: 6224); Dichloromethane (PubChem CID: 6344); Enrofloxacin; Enrofloxacin (PubChem CID: 71188); Microparticles; Polyvinyl alcohol (PubChem CID: 11199); Potassium chloride (PubChem CID: 4873); Preparation; Sodium alginate (PubChem CID: 5102882); Sodium chloride (PubChem CID: 5234); Sodium hydrogen carbonate (PubChem CID: 516892); Sodium hydroxide (PubChem CID: 14798); Sodium phosphate monobasic (PubChem CID: 23672064); Sodium sulfuret (PubChem CID: 14804); Stearic acid (PubChem CID: 5281); Taste-masking; Urea (PubChem CID: 1176).

PubMed Disclaimer

LinkOut - more resources